Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox for HTLV-1-associated tropical spastic paraparesis
RBR-67ynvtRecruiting
- Sponsor
- Hospital Universitário Professor Edgard Santos
- Start
- Jun 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial of botulinum toxin type A in HTLV-1-associated myelopathy (HAM) (2 arms), sponsored by Hospital Universitário Professor Edgard Santos. Started Jun 2018; status: recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
HTLV-1-associated myelopathy (HAM)
Beyond the preview
Go deeper on RBR-67ynvt.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-67ynvt.